Active Ingredient History
Ustekinumab, sold under the brand name Stelara among others, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, targeting both IL-12 and IL-23. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Arthritis, Juvenile (Phase 3)
Arthritis, Rheumatoid (Phase 2)
Autoimmune Diseases (Phase 2)
Axial Spondyloarthritis (Phase 3)
Behcet Syndrome (Phase 2)
Carcinoma, Giant Cell (Phase 2)
Cardiovascular Diseases (Phase 4)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 4)
Crohn Disease (Phase 4)
Dermatitis, Allergic Contact (Phase 2/Phase 3)
Dermatitis, Atopic (Phase 2)
Dermatomyositis (Phase 3)
Diabetes Mellitus, Type 1 (Phase 2/Phase 3)
Diagnosis (Phase 2)
Giant Cell Arteritis (Phase 1/Phase 2)
Graft vs Host Disease (Phase 2)
Healthy Volunteers (Phase 1)
Hidradenitis Suppurativa (Phase 2)
Ichthyosis (Phase 4)
Inflammation (Phase 2/Phase 3)
Inflammatory Bowel Diseases (Phase 4)
Intestinal Diseases (Phase 1/Phase 2)
Intestinal Neoplasms (Phase 1/Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukocytes (Phase 2)
Liver Cirrhosis, Biliary (Phase 2)
Lupus Erythematosus, Systemic (Phase 3)
Lymphoma (Phase 2)
Multiple Sclerosis (Phase 2)
Neoplasms (Phase 2)
Pemphigoid, Bullous (Phase 2)
Polymyositis (Phase 3)
Pouchitis (Phase 3)
Psoriasis ()
Sarcoidosis (Phase 2)
Sjogren's Syndrome (Phase 1)
Spondylitis, Ankylosing (Phase 3)
Substance Withdrawal Syndrome (Phase 3)
Takayasu Arteritis (Phase 3)
Uveitis (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
